Package Leaflet: Information for the User
Dupixent 200 mg solution for injection in pre-filled syringe
dupilumab
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
What is Dupixent
Dupixent contains the active substance dupilumab.
Dupilumab is a monoclonal antibody (a special type of protein) that blocks the action of proteins called interleukins (IL)-4 and IL-13. Both play a key role in the appearance of signs and symptoms of atopic dermatitis and asthma.
What is it used for
Dupixent is used to treat adults and adolescents from 12 years of age with moderate to severe atopic dermatitis, also known as atopic eczema. Dupixent is also used to treat children from 6 months to 11 years of age with severe atopic dermatitis. Dupixent can be used with medicines for eczema that are applied to the skin or can be used alone.
Dupixent is also used, along with other medicines for asthma, for the maintenance treatment of severe asthma in adults, adolescents, and children from 6 years of age whose asthma is not controlled with their current medication (e.g. corticosteroids).
Dupixent is also used to treat adults, adolescents, and children from 1 year of age, with a minimum weight of 15 kg, with eosinophilic esophagitis (EoE).
How Dupixent works
Using Dupixent for atopic dermatitis (atopic eczema) may improve your skin condition and reduce itching. Dupixent has also shown an improvement in symptoms of pain, anxiety, and depression associated with atopic dermatitis. Additionally, Dupixent helps improve sleep disorders and your overall quality of life.
Dupixent helps prevent severe asthma attacks (exacerbations) and may improve your breathing ability. Dupixent may also help reduce the amount of another group of medicines you need to control your asthma, called oral corticosteroids, while preventing severe asthma attacks and improving your breathing ability.
Do not use Dupixent
If you think you may be allergic, or are unsure, consult your doctor, pharmacist, or nurse before using Dupixent.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting Dupixent:
Dupixent is not a rescue medicineand should not be used to treat a sudden asthma attack.
Each time you have a new pack of Dupixent, it is important that you note the name of the medicine, the date of administration, and the batch number (which is found on the packaging after “Batch”) and keep this information in a safe place.
Allergic reactions
Eosinophilic diseases
Parasitic infection (intestinal parasites)
Asthma
If you have asthma and are taking asthma medication, do not change or stop taking your asthma medication without consulting your doctor. Consult your doctor before stopping treatment with Dupixent or if your asthma is not controlled or worsens during treatment with this medicine.
Eye problems
Talk to your doctor if eye problems appear or worsen, including eye pain or changes in vision.
Children and adolescents
Other medicines and Dupixent
Tell your doctor or pharmacist
Other asthma medicines
Do not stop or reduce your asthma medicines unless your doctor tells you to.
Pregnancy and breastfeeding
Driving and using machines
Dupixent is unlikely to affect your ability to drive or use machines.
Dupixent contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per 200 mg dose; this is essentially “sodium-free”.
Dupixent contains polysorbate
This medicine contains 2.28 mg of polysorbate 80 in each 200 mg dose (1.14 ml). Polysorbates may cause allergic reactions. Tell your doctor if you or your child have any known allergy.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
What dose of Dupixent you will receive
Your doctor will decide what dose of Dupixent is suitable for you.
Recommended dose in adolescents with atopic dermatitis
The recommended dose of Dupixent for adolescents (12 to 17 years of age) with atopic dermatitis is based on body weight:
Patient’s body weight | Initial dose | Subsequent doses (every 2 weeks) |
less than 60 kg | 400 mg (two 200 mg injections) | 200 mg |
60 kg or more | 600 mg (two 300 mg injections) | 300 mg |
Recommended dose in children 6 to 11 years of age with atopic dermatitis
The recommended dose of Dupixent for children (6 to 11 years of age) with atopic dermatitis is based on body weight:
Patient’s body weight | Initial dose | Subsequent doses |
15 kg to less than 60 kg | 300 mg (one 300 mg injection) on day 1, followed by 300 mg on day 15 | 300 mg every 4 weeks*, starting 4 weeks after the day 15 dose |
60 kg or more | 600 mg (two 300 mg injections) | 300 mg every 2 weeks |
Recommended dose in children 6 months to 5 years of age with atopic dermatitis
The recommended dose of Dupixent for children 6 months to 5 years of age with atopic dermatitis is based on body weight:
Patient’s body weight | Initial dose | Subsequent doses |
5 kg to less than 15 kg | 200 mg (one 200 mg injection) | 200 mg every 4 weeks |
15 kg to less than 30 kg | 300 mg (one 300 mg injection) | 300 mg every 4 weeks |
Recommended dose in adult and adolescent patients with asthma (from 12 years of age)
For most patients with severe asthma, the recommended dose of Dupixent is:
For patients with severe asthma who are taking oral corticosteroids or for patients with severe asthma and moderate to severe comorbid atopic dermatitis or adults with severe comorbid chronic rhinosinusitis with nasal polyposis, the recommended dose of Dupixent is:
Recommended dose in children with asthma
The recommended dose of Dupixent for children (6 to 11 years of age) with asthma is based on body weight:
Patient’s body weight | Initial and subsequent doses |
15 kg to less than 30 kg | 300 mg every 4 weeks |
30 kg to less than 60 kg | 200 mg every 2 weeks or 300 mg every 4 weeks |
60 kg or more | 200 mg every 2 weeks |
For patients 6 to 11 years of age with asthma and severe comorbid atopic dermatitis, your doctor will decide what dose of Dupixent is suitable for you.
Recommended dose in adults, adolescents, and children (from 1 year of age) with eosinophilic esophagitis (EoE)
Body weight | Dose |
≥15 kg to <30 kg | 200 mg every 2 weeks |
≥30 kg to <40 kg | 300 mg every 2 weeks |
≥40 kg | 300 mg every week |
Dupixent injection
Dupixent is administered by injection under your skin (subcutaneous injection). You and your doctor or nurse should decide if you should inject Dupixent yourself.
Before you inject Dupixent yourself, you must have been properly trained by your doctor or nurse. Your Dupixent injection can also be given by a caregiver after proper training by a doctor or nurse. Each pre-filled syringe contains one dose of Dupixent (200 mg). Do not shake the pre-filled syringe. Carefully read the “Instructions for Use” included at the end of the package leaflet before using Dupixent.
If you use more Dupixent than you should
If you use more Dupixent than you should or have been given the dose too soon, consult your doctor, pharmacist, or nurse.
If you forget to use Dupixent
If you have forgotten to inject a dose of Dupixent, consult your doctor, pharmacist, or nurse.
Additionally,
If your dosing schedule is every weekand you miss a dose of Dupixent:
If your dosing schedule is every 2 weeksand you miss a dose of Dupixent:
If your dosing schedule is every 4 weeksand you miss a dose of Dupixent:
If you stop treatment with Dupixent
Do not stop treatment with Dupixent without first talking to your doctor.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Dupixent may cause serious side effects, including rare allergic reactions (hypersensitivity), including anaphylactic reaction, serum sickness, serum sickness-like reaction; the signs may include:
If you develop an allergic reaction, stop using Dupixent and consult your doctor immediately.
Other side effects
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Additional side effects in children 6 to 11 years of age with asthma
Common: worms (enterobiasis)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month shown.
Store in a refrigerator (2°C to 8°C). Do not freeze. Keep the pre-filled syringe in the original package to protect it from light.
If necessary, the pre-filled syringe can be removed from the refrigerator and stored in the carton at room temperature up to 25°C for a maximum of 14 days. The date it is removed from the refrigerator will be noted on the space provided on the outer carton. The carton should be discarded if it is left out of the refrigerator for more than 14 days or if it has passed the expiry date.
Do not use this medicine if you notice that the medicine is cloudy, discolored, or contains particles.
Medicines should not be disposed of via wastewater or household waste. Ask your doctor, pharmacist, or nurse how to dispose of medicines no longer required. This will help protect the environment.
Dupixent Composition
Product Appearance and Container Contents
Dupixent is a clear to slightly opalescent, colorless to pale yellow solution presented in a glass pre-filled syringe with a needle shield.
Dupixent is available as 200 mg pre-filled syringes in a container containing 1 or 2 pre-filled syringes or in a multi-pack container containing 6 (3 packs of 2) pre-filled syringes.
Only some pack sizes may be marketed.
Marketing Authorization Holder
Sanofi Winthrop Industrie
82 avenue Raspail
94250 Gentilly
France
Manufacturer
SANOFI WINTHROP INDUSTRIE 1051 Boulevard Industriel,
76580 LE TRAIT,
FRANCE Sanofi-Aventis Deutschland GmbH Brüningstrasse 50 Industriepark Hoechst 65926 FRANKFURT AM MAIN GERMANY
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 | Lietuva Swixx Biopharma UAB Tel: +370 5 236 91 40 |
Luxembourg/Luxemburg Sanofi Belgium Tél/Tel: +32 (0)2 710 54 00 (Belgique/Belgien) | |
Ceská republika Sanofi, s.r.o. Tel: +420 233 086 111 | Magyarország SANOFI-AVENTIS Zrt. Tel.: +36 1 505 0050 |
Danmark Sanofi A/S Tlf: +45 45 16 70 00 | Malta Sanofi S.r.l. Tel: +39 02 39394275 |
Deutschland Sanofi-Aventis Deutschland GmbH Tel.: 0800 04 36 996 Tel. from abroad: +49 69 305 70 13 | Nederland Sanofi B.V. Tel: + 31 20 245 4000 |
Eesti Swixx Biopharma OÜ Tel: +372 640 10 30 | Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 |
Ελλάδα Sanofi-Aventis Μονοπρ?σωπη AEBE Τηλ: +30 210 900 16 00 | Österreich sanofi-aventis GmbH Tel: +43 1 80 185 – 0 |
España sanofi-aventis, S.A. Tel: +34 93 485 94 00 | Polska Sanofi Sp. z o.o. Tel.: +48 22 280 00 00 |
France Sanofi Winthrop Industrie Tél: 0 800 222 555 Call from abroad: +33 1 57 63 23 23 | Portugal Sanofi - Produtos Farmacêuticos, Lda Tel: +351 21 35 89 400 |
Hrvatska Swixx Biopharma d.o.o. Tel: +385 1 2078 500 | România Sanofi Romania SRL Tel: +40 (0) 21 317 31 36 |
Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 00 | Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51 00 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 600 |
Italia Sanofi S.r.l. Tel: 800 536389 | Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200 300 |
Κ?προς C.A. Papaellinas Ltd. Τηλ: +357 22 741741 | Sverige Sanofi AB Tel: +46 (0)8 634 50 00 |
Latvija Swixx Biopharma SIA Tel: +371 6 616 47 50 | United Kingdom(Northern Ireland) sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2525 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.
--------------------------------------------------------------------------------------------------------------------
Dupixent 200mg solution for injection in pre-filled syringe with needle shield
dupilumab
Instructions for Use
This drawing shows the parts of the Dupixent pre-filled syringe with needle shield.
Important Information
This device is a single-use pre-filled syringe. It contains 200 mg of Dupixent for injection under the skin (subcutaneous injection).
Do not attempt to administer the injection to yourself or another person unless you have been trained by your healthcare professional. In adolescents from 12 years of age, it is recommended that Dupixent be administered by or under the supervision of an adult. In children under 12 years of age, Dupixent should be administered by a caregiver.
Storage of Dupixent
Step 1: Remove
Remove the syringe from the container by holding it in the middle of the syringe body.
Do not remove the needle shield until you are ready for injection.
Do not use the syringe if it has been dropped onto a hard surface or if it has been damaged.
Step 2: Prepare
Make sure you have:
Check the label:
Do not use the syringe if the expiration date has passed.
Do not store Dupixent at room temperature for more than 14 days.
Step 3: Check
Look at the medicine through the viewing window of the syringe:
Check that the liquid is clear and colorless to pale yellow.
Note: you may see an air bubble, which is normal.
Do not use the syringe if the liquid is cloudy or discolored, or if it contains flakes or particles.
Step 4: Wait 30minutes
Place the syringe on a flat surface for at least 30 minutes and let it reach room temperature naturally.
Do not heat the syringe in a microwave, hot water, or direct sunlight.
Do not expose the syringe to direct sunlight.
Do not store Dupixent at room temperature for more than 14 days.
Step 5: Choose
Select the injection site.
Do not inject into sensitive, damaged, or scarred skin.
Step 6: Clean
Wash your hands.
Disinfect the injection site with an alcohol swab.
Let the skin dry before proceeding with the injection.
Do not touch the injection site or blow on it before injection.
Step 7: Pull
Hold the syringe by the middle of the syringe body, with the needle pointing away from you, and pull off the needle shield.
Do not put the needle shield back on the needle.
Do not touch the needle.
Inject the medicine immediately after removing the needle shield.
Step 8: Pinch
Pinch a fold of skin at the injection site, as shown in the drawing.
Step 9: Insert
Insert the needle completely into the fold of skin at an angle of approximately 45°.
Step 10: Push
Release the pinch.
Push the plunger rod down slowly and continuously until it stops and the syringe is empty.
Note: you will feel a little resistance, which is normal.
Step 11: Release and Remove
Lift your thumb to release the plunger rod until the needle is covered by the needle shield, then remove the syringe from the injection site.
If you see a little blood, press gently on the injection site with a cotton ball or gauze.
Do not put the needle shield back on the needle.
Do not rub the skin after injection.
Step 12: Dispose
Throw away the syringe and needle shield in a sharps container.
Do not put the needle shield back on the needle.
Always keep the container out of the reach of children.